Susan Hasty, Publisher
Table of Contents . . . December 5th, 2004
Non-Subscriber - Summaries OnlyRelated Areas: Other Issues in Oncology Business Week | Other Publications
Amgen Inc. - Panitumumab with chemotherapy shows promise as colorectal cancer treatment
AstraZeneca - New data presented gefitinib's antitomor activity
Aventis - E.U. approves Taxotere (docetaxel) in prostate cancer
Celgene Corporation - FDA issues approvable letter for Thalomid sNDA
Cell Genesys, Inc. - Oncology company reports loss of $0.54 per share
CuraGen Corp. - Company details clinical development plan for CG53135 and CR002
Dendreon Corp. - Company achieves commercial scale of antigen for Provenge
Electro-Optical Sciences, Inc - Vision technology firm raises $9M, obtains protocol agreement for MelaFind
Generex Biotechnology Corporation - Melanoma vaccination results presented at conference
Genzyme Corp. - Company seeks new therapeutic indication for Thyrogen
GlaxoSmithKline - Study results show anti-tumor activity
MGI Pharma - NDA for anticancer therapeutic drug submitted to U.S. FDA by two drug companies
Matritech, Inc. - Cancer diagnostics company reports 65% increase in third quarter revenue
NeoPharm - Biopharma company presents data on NeoLipid compound, releases financial results
NeoRx Corporation - Cancer therapeutics development company reports financial results
ACLARA BioSciences - Clinical data shows eTag's potential in predicting response to cancer treatment
Amrad Corporation Limited - Cancer research deal signed for development of VEGF-B
Ariad Pharmaceuticals, Inc. - Pharmaceutical company appoints Peter J. Nelson to board
Boston Scientific Corporation - New treatment for uterine fibroids called safe and effective
Breast Cancer - Tc-99m-MIBI scintimammography inappropriate for routine evaluation of lesions
Breast Cancer Prevention - South Carolina breast cancer program should be expanded to include more women
Bristol-Myers Squibb - Trials show hepatitis B agent a statistical improvement in infected patients
British Columbia Cancer Agency - Ras oncogene uses dual modes to oppose colon cancer cell p53 expression
Center for Genetic Engineering & Biotechnology - Coadministered antigens may afford better protection against hepatitis B
Colorectal Cancer - Caffeinated coffee, but not decaf or tea, may have some protective effect
Danish Cancer Society - Preoperative plasma suPAR levels not useful as prognostic indicator
Dartmouth Medical School - HPV vaccine shown to "substantially" reduce cervical cancer
Disease Risk - Families should catalog medical history
Edinburgh University - It's time to allow people to die at home with dignity, say researchers
Endocare, Inc. - Device company inks research agreement with Columbia University Medical Center
Environmental Health - High toxic chemical levels found in Duwamish River area of Washington
Erasmus Medical Centre, Rotterdam - Basal cell carcinoma rates continuously increasing in the Netherlands since 1973
Frost & Sullivan - Study indicates new uses for therapies in treating non-small cell lung cancer
Given Imaging - Small bowel tumors study data presented at conference
I-Flow Corporation - Infusion systems developer announces 58% increase in third quarter revenues
IMPAC Medical Systems, Inc. - Oncology IT solutions company announces filing of Form 10-K/A
INSERM U396, Paris - Imatinib does not normalize blood dendritic cell levels in leukemia patients
INSERM U584, Paris - The antiangiogenic properties of 16K prolactin are still undefined in humans
INSERM, U597, Nice - PI3K mediates protection against TRAIL-induced apoptosis in melanocytes
Intercell AG - Centrosome-associated PIBF gene is overexpressed in highly proliferating cells
Johns Hopkins University - M4N induces growth arrest/apoptosis by inhibiting Cdc2 and survivin expression
Johnson & Johnson Pharmaceutical R&D, LLC - Estrogen regulates GILZ gene in cell-specific manner
Kagawa University - Motility-related protein-1 cuts off tumor metastasis by suppressing Wnt signals
Kagoshima University - Wild-type breast cancer resistance protein induces cellular resistance to NRTIs
Kansai Medical University - Total number of cancer cells reflects prognosis
Kobe University - CD25 T cell depletion and interleukin-12 gene transfer staunch melanoma growth
Lund University - Prognostic value of Ki-67 confirmed
M.D. Anderson Cancer Center - H-DNA-forming sequences cause mammalian cell mutations
M.D. Anderson Cancer Center - Neural SC REST/NRSF gene activation sufficient to cause neuronal differentiation
Marshall Edwards, Inc. - U.S. FDA fast-tracks phenoxodiol for recurrent ovarian cancer
Massey University - Childhood obesity increases later cancer risk, especially for smokers
Maxim Pharmaceuticals - Negative outcome on malignant melanoma trial reported
Mayo Clinic - Transforming growth factor regulates angiogenic factors in pituitary cells
MediGene AG - License agreement for cancer-killing herpes virus concluded
Meditech Research Limited - Colon cancer trial information presented at conference
National Taiwan University Hospital - Adenovirus vectors that express Fas ligand may treat allergic asthma
National Taiwan University Hospital - Allelic loss on chromosome 4q is linked to hepatitis B-related liver cancer
Natl. Autonomous Univ. of Mexico - Two pathways can activate IL-2 receptor signaling in HPV-associated cancer
Natl. Inst. of Radiologic Science, Japan - Lonidamine plus radiation increase melanoma cell apoptosis
Northwestern University - Researchers investigate effect of tomato oil on precancerous prostate changes
Oakland University - Edpm5 guides the control of angiogenesis in rodent pituitary tumors
Ohio State University - Role of cancer-associated stromal fibroblasts in liver metastasis determined
Oncolytics Biotech Inc. - Biotech company announces issuance of reovirus patent
Onyx Pharmaceuticals, Inc. - Pharma company reports third quarter and 9 month 2004 financial results
Osaka National Hospital - Virological responders to hepatitis therapy retain mild liver inflammation
Osaka University - IL-6 regulates dendritic cell differentiation through STAT3 activation
Osaka University - Microbubble-enhanced ultrasound augments central nerve system transfection
Peking University - Genes with unique expression in liver cancers may be drug targets
Pharmacopeia Drug Discovery, Inc. - Drug discovery company announces third quarter 2004 results
Pharmacyclics, Inc. - Pharma company presents data on Xcytrin Injection trial
Professor Alexander Posadas National Hospital - Obesity delineates nonalcoholic steatohepatitis fibrosis progression
Progenics Pharmaceuticals - Pharma companies awarded NIH grants for prostate cancer immunotherapies
R2 Technology, Inc. - Computer-aided detection technology company appoints chief financial officer
RITA Medical Systems, Inc. - Medical oncology device company announces third quarter, 9-month results
RITA Medical Systems, Inc. - Pilot study examines new radiofrequency ablation-assisted lumpectomy
Rejuvenon Corporation - Pharma company appoints president and CEO
Roche Oncology - Oral targeted colon cancer drug shown to improve outcomes, cut post-op costs
Roswell Park Cancer Institute - Polystyrene bead system useful in CTL activity analysis
Russells Hall Hospital, U.K. - Intra-operative specimen radiographs help minimize necessary tissue excision
Sapporo Medical University - Suppressed E1AF limits the invasiveness of cervical cancer
Schering-Plough Corporation - FDA grants priority review status for brain tumor drug; EMEA application made
Seoul National University - Mature yuzu could be a significant dietary source of antioxidants
Signet Laboratories - Lab announces availability of monoclonal antibody for detecting prostate cancer
Smoking Ban - Second Nevada petition would restrict smoking in public
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.